Inflammation and wasting in chronic kidney disease: Partners in crime

被引:71
作者
Avesani, C. M. [1 ]
Carrero, J. J. [1 ]
Axelsson, J. [1 ]
Qureshi, A. R. [1 ]
Lindholm, B. [1 ]
Stenvinkel, P. [1 ]
机构
[1] Karolinska Inst, Div Baxter Novum & Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
关键词
inflammation; cytokines; muscle wasting; sarcopenia; chronic kidney disease;
D O I
10.1038/sj.ki.5001969
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Protein energy malnutrition (PEM) is often present in patients with chronic kidney disease with or without ongoing renal replacement therapy. Muscle wasting (sarcopenia) is one of the hallmarks of PEM in these patients and recent studies have reported a link between sarcopenia and inflammation. The low-grade inflammation often observed in end-stage renal disease (ESRD) can lead to sarcopenia through an increase in protein catabolism, a decrease in protein syntheses or both. The activation of the ATP-ubiquitin-proteasome pathway, insulin resistance, hypermetabolism, and decreased appetite are all plausible pathophysiological pathyways whereby inflammation can contribute to sarcopenia and PEM. In the present review we discuss these interactions between inflammation and wasting in ESRD patients and explore putative pathways involved in this condition.
引用
收藏
页码:S8 / S13
页数:6
相关论文
共 39 条
[1]
Eating behavior disorders in uremia:: A question of balance in appetite regulation [J].
Aguilera, A ;
Codoceo, R ;
Bajo, MA ;
Iglesias, P ;
Diéz, JJ ;
Barril, G ;
Cigarrán, S ;
Alvarez, V ;
Celadilla, O ;
Fernández-Perpén, A ;
Montero, A ;
Selgas, R .
SEMINARS IN DIALYSIS, 2004, 17 (01) :44-52
[2]
Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients:: their relationship with nutritional parameters [J].
Aguilera, A ;
Codoceo, R ;
Selgas, R ;
Garcia, P ;
Picornell, M ;
Diaz, C ;
Sanchez, C ;
Bajo, MA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (06) :1476-1483
[3]
Resting energy expenditure in pre-dialysis diabetic patients [J].
Avesani, CM ;
Cuppari, L ;
Silva, AC ;
Sigulem, DM ;
Cendoroglo, M ;
Sesso, R ;
Draibe, SA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) :556-560
[4]
Truncal fat mass as a contributor to inflammation in end-stage renal disease [J].
Axelsson, J ;
Qureshi, AR ;
Suliman, ME ;
Honda, H ;
Pecoits-Filho, R ;
Heimbürger, O ;
Lindholm, B ;
Cederholm, T ;
Stenvinkel, P .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (05) :1222-1229
[5]
Effects of etanercept in patients with the metabolic syndrome [J].
Bernstein, LE ;
Berry, J ;
Kim, S ;
Canavan, B ;
Grinspoon, SK .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (08) :902-908
[6]
Buttgereit F, 2000, IMMUNOL TODAY, V21, P192
[7]
Induction of leptin resistance through direct interaction of C-reactive protein with leptin [J].
Chen, K ;
Li, FH ;
Li, J ;
Cai, HB ;
Strom, S ;
Bisello, A ;
Kelley, DE ;
Friedman-Einat, M ;
Skibinski, GA ;
McCrory, MA ;
Szalai, AJ ;
Zhao, AZ .
NATURE MEDICINE, 2006, 12 (04) :425-432
[8]
Chiolero R, 1997, NUTRITION, V13, P45
[9]
Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis [J].
Costelli, P ;
Baccino, FM .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (04) :407-412
[10]
Delano Matthew J, 2006, Nutr Clin Pract, V21, P68, DOI 10.1177/011542650602100168